Finance News – U.S.

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Tariffs Investors Ceo Stock Earnings Shares Stocks Eqs China Nasdaq Cet Markets Investment Wall Street Trade Tesla Revenue Nvidia Stock Market Class Action Securities Economy Bitcoin Inflation Us Sales Company Trade War Prices Apple Federal Reserve Sp 500 Pvr Crypto Interest Rates Guidance Companies Warren Buffett Ipo Amazon Berkshire Hathaway Shareholders Federal Securities Laws Walmart Profit Voting Rights Investor German Securities Trading Act Trading Elon Musk Jpmorgan Economist Tokens Taco Trade Token2049 Withholding Asset Backed Securitization T Mobile Lease Agreement Charging

Filter by:

Trpv3 Inhibitor × U.S. × Past year ×

Business Insider Markets • Jun 03, 2025

Kamari Pharma Announces Closing of $23 Million Financing to Advance its First-In-Class Oral TRPV3 In...

Kamari Pharma secured $23 million in funding led by BRM Group and Pontifax to support the clinical development of its novel oral TRPV3 inhibitor targeting rare genetic skin conditi...

Read Full Article →